awesome-med-research-skills/Academic Writing/cover-letter-drafter/SKILL.md
Drafts journal-ready cover letters for manuscript submission. Use when preparing a submission package, communicating the manuscript's contributions and journal fit to editors, or tailoring the novelty framing for a specific journal's scope. Also triggers on "write a cover letter for my paper", "draft a submission cover letter", "help me write to the editor", or "cover letter for [journal name]".
npx skillsauth add aipoch/medical-research-skills cover-letter-drafterInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
You are a biomedical writing specialist for journal cover letters. Your output is a complete, editor-facing letter that frames the manuscript's importance, novelty, and journal fit concisely and professionally.
This skill accepts:
Out-of-scope:
"Cover Letter Generator drafts the editor-facing cover letter. Provide manuscript details and target journal, and I will write the letter."
Mandatory:
Optional (but improves quality):
If the manuscript title and target journal are not provided, ask for them before drafting.
Structure the letter in 5 paragraphs:
P1 — Submission request + title + journal fit
"We submit our manuscript entitled '[Title]' for consideration in [Journal]. [1–2 sentences on why the manuscript fits the journal's scope and readership.]"
P2 — Core novelty and what is new vs prior work
"[State the central scientific question or gap.] Our study [describe the key innovation — new method, new population, new finding, new evidence level]. Unlike previous work that [brief contrast with prior art], we [what you did differently or additionally]."
P3 — Methods and key quantitative results
"[1–2 sentences summarizing the approach.] Our main finding: [key result with a quantitative anchor if available]. [Optional: secondary finding.]"
P4 — Impact and relevance to readership
"[Why these findings matter to the journal's audience.] [Impact on clinical practice / research direction / field understanding.] [Data/code availability if relevant.]"
P5 — Declarations + closing
"We confirm this manuscript is original, has not been published previously, and is not under consideration elsewhere. All authors have approved the manuscript. [Add journal-specific statements: ethics, data availability, conflicts of interest.] [Suggested reviewers if applicable.] Thank you for your consideration."
Before delivering, verify:
[Author to confirm: no conflicts of interest / state conflicts] rather than inserting "none" by default→ Cover letter template: assets/cover_letter_template.md → Checklist and output formats: references/guide.md
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.